These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 37515066)

  • 1. Use of Information and Communication Technology Strategies to Increase Vaccination Coverage in Older Adults: A Systematic Review.
    Buja A; Grotto G; Taha M; Cocchio S; Baldo V
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Behaviour Change Techniques within Interventions to Increase Vaccine Uptake among Ethnic Minority Populations.
    Ekezie W; Connor A; Gibson E; Khunti K; Kamal A
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Infection, Vaccination, and Antibody Levels: Investigating Correlations through a Cohort Study.
    Kayalı GA; Durmaz S; Şahin İN; Akkul B; Durusoy R; Akarca FK; Ulukaya S; Çiçek C
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2.
    Pichler R; Diem G; Hackl H; Koutník J; Mertens LS; D Andrea D; Pradere B; Soria F; Mari A; Laukhtina E; Krajewski W; Teoh JY; Del Guidice F; Moschini M; Thurnher M; Posch W
    Front Immunol; 2023; 14():1202157. PubMed ID: 37520557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 inactivated and non-replicating viral vector vaccines induce regulatory training phenotype in human monocytes under epigenetic control.
    Antunes MDSM; Sugiyama FHC; Gravina HD; Castro RC; Mercado FJR; de Lima JO; Fontanari C; Frantz FG
    Front Cell Infect Microbiol; 2023; 13():1200789. PubMed ID: 37520439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients.
    Souan L; Abdel-Razeq H; Al Zughbieh M; Al Badr S; Sughayer MA
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccination Personas in Yemen: Insights from Three Rounds of a Cross-Sectional Survey.
    Nikoloski Z; Chimenya D; Alshehari A; Hassan H; Bain R; Menchini L; Gillespie A
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System Biology Approach to Identify the Hub Genes and Pathways Associated with Human H5N1 Infection.
    Chaudhary RK; L A; Patil P; Mateti UV; Sah S; Mohanty A; Rath RS; Padhi BK; Malik S; Jassim KH; Al-Shammari MA; Waheed Y; Satapathy P; Barboza JJ; Rodriguez-Morales AJ; Sah R
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Vaccination: Knowledge, Attitudes and Practices of People Working on Illegal Gold Mining Sites in French Guiana.
    Durand P; Basurko C; Vreden S; Nacher M; Douine M
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria.
    Khalid K; Poh CL
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases.
    Edelman-Klapper H; Rabinowitz KM; Zittan E; Bar-Gil Shitrit A; Goren I; Avni-Biron I; Ollech JE; Lichtenstein L; Banai-Eran H; Yanai H; Snir Y; Pauker MH; Friedenberg A; Levy-Barda A; Broitman Y; Ben Zvi H; Perets TT; Eliakim R; Barkan R; Goren S; Cohen D; Dotan I;
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Testing Positive for COVID-19 among Healthcare and Healthcare-Related Workers.
    Ríos-Bracamontes EF; Iñiguez-Arias LE; Ochoa-Jiménez RJ; Guzmán-Esquivel J; Cárdenas-Rojas MI; Murillo-Zamora E
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
    Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
    J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.
    Sun S; Li E; Zhao G; Tang J; Zuo Q; Cai L; Xu C; Sui C; Ou Y; Liu C; Li H; Ding Y; Li C; Lu D; Zhang W; Luo P; Cheng P; Gao Y; Tu C; Pitard B; Rosenecker J; Wang B; Liu Y; Zou Q; Guan S
    Biomaterials; 2023 Jan; 292():121907. PubMed ID: 36436305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal vaccines for SARS-CoV-2: triumph of hope over experience.
    Pilapitiya D; Wheatley AK; Tan HX
    EBioMedicine; 2023 Jun; 92():104585. PubMed ID: 37146404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice.
    Ashhurst AS; Johansen MD; Maxwell JWC; Stockdale S; Ashley CL; Aggarwal A; Siddiquee R; Miemczyk S; Nguyen DH; Mackay JP; Counoupas C; Byrne SN; Turville S; Steain M; Triccas JA; Hansbro PM; Payne RJ; Britton WJ
    Nat Commun; 2022 Nov; 13(1):6972. PubMed ID: 36379950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Common Mucosal System Fifty Years on: From Cell Traffic in the Rabbit to Immune Resilience to SARS-CoV-2 Infection by Shifting Risk within Normal and Disease Populations.
    Clancy Am R
    Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection.
    Ahuja SK; Manoharan MS; Lee GC; McKinnon LR; Meunier JA; Steri M; Harper N; Fiorillo E; Smith AM; Restrepo MI; Branum AP; Bottomley MJ; Orrù V; Jimenez F; Carrillo A; Pandranki L; Winter CA; Winter LA; Gaitan AA; Moreira AG; Walter EA; Silvestri G; King CL; Zheng YT; Zheng HY; Kimani J; Blake Ball T; Plummer FA; Fowke KR; Harden PN; Wood KJ; Ferris MT; Lund JM; Heise MT; Garrett N; Canady KR; Abdool Karim SS; Little SJ; Gianella S; Smith DM; Letendre S; Richman DD; Cucca F; Trinh H; Sanchez-Reilly S; Hecht JM; Cadena Zuluaga JA; Anzueto A; Pugh JA; ; Agan BK; Root-Bernstein R; Clark RA; Okulicz JF; He W
    Nat Commun; 2023 Jun; 14(1):3286. PubMed ID: 37311745
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.